The Charles Schwab Corporation
The Charles Schwab Corporation (SCHW) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for The Charles Schwab Corporation (SCHW), featuring income statements, balance sheets, and cash flow data.
The Charles Schwab Corporation (SCHW) Income Statement & Financial Overview
Analyze The Charles Schwab Corporation’s SCHW earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $6.65B | $6.65B | $6.55B | $6.35B |
| Cost of Revenue | $1.05B | $1.39B | $1.71B | $1.66B |
| Gross Profit | $5.41B | $5.33B | $4.85B | $4.69B |
| Gross Profit Ratio | $0.81 | $0.80 | $0.74 | $0.74 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $1.77B | $1.63B | $1.62B | $1.56B |
| Operating Expenses | $3.14B | $3.02B | $3.005B | $2.94B |
| Total Costs & Expenses | $3.47B | $4.35B | $4.71B | $4.60B |
| Interest Income | $3.76B | $3.85B | $3.93B | $3.82B |
| Interest Expense | $1.05B | $1.32B | $1.71B | $1.66B |
| Depreciation & Amortization | $347.00M | $354.00M | $361.00M | $362.00M |
| EBITDA | $2.80B | $2.66B | $2.20B | $2.11B |
| EBITDA Ratio | $0.42 | $0.40 | $0.34 | $0.33 |
| Operating Income | $2.46B | $2.31B | $1.84B | $1.75B |
| Operating Income Ratio | $0.37 | $0.35 | $0.28 | $0.28 |
| Other Income/Expenses (Net) | $0.00 | $0.00 | $0.00 | $0.00 |
| Income Before Tax | $2.46B | $2.31B | $1.84B | $1.75B |
| Income Before Tax Ratio | $0.37 | $0.35 | $0.28 | $0.28 |
| Income Tax Expense | $546.00M | $465.00M | $434.00M | $415.00M |
| Net Income | $1.91B | $1.84B | $1.41B | $1.33B |
| Net Income Ratio | $0.29 | $0.28 | $0.21 | $0.21 |
| EPS | $0.99 | $0.94 | $0.71 | $0.66 |
| Diluted EPS | $0.99 | $0.94 | $0.71 | $0.66 |
| Weighted Avg Shares Outstanding | $1.82B | $1.83B | $1.83B | $1.83B |
| Weighted Avg Shares Outstanding (Diluted) | $1.82B | $1.84B | $1.83B | $1.83B |
Over the past four quarters, The Charles Schwab Corporation demonstrated steady revenue growth, increasing from $6.35B in Q2 2024 to $6.65B in Q1 2025. Operating income reached $2.46B in Q1 2025, maintaining a consistent 37% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $2.80B, reflecting operational efficiency. Net income rose to $1.91B, with EPS at $0.99. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan